Neogenomics Inc NASDAQ NMS - GLOBAL MARKET:NEO
The leadership team, board of directors, and 10% beneficial owners of Neogenomics Inc, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
Aunan Greg D
—22,027 sharesKelly Michael Aaron
—5,000 sharesOlivo Alicia C
—93,224 sharesPerez David Brian
—10,000 sharesStone Warren
—147,714 sharesTETRAULT LYNN A.
—7,000 sharesZook Anthony P.
—18,900 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.